CNTG: centogene.com Book Value of Business

Centogene N.V. (CNTG) is managed by specialized genetics experts who ensure reporting transparency and adherence to medical standards. This price chart reflects a market trend for the asset at 0.00. The business relies on the diagnosis of rare pathologies for clinics and pharmaceutical companies. Operational stability is supported by the neutral status of biomedicine, which minimizes the impact of global conflicts and sanction restrictions.

CNTG Centogene N.V. Book Capitalization (07/04/2022 - 08/17/2024)

Centogene N.V. - analytical breakdowns and key metrics (CNTG)

- price and consensus price forecast:

Price CENTOGENE, N.V.|CNTG - Analyst Consensus Forecast

- market capitalization data:

Market Capitalization Centogene NV|CNTG - Total Company Value

- book capitalization data:

Accounting Value per Share CENTOGENE|CNTG - Book Capitalization|Market-to-Book Ratio centogene.com|CNTG - Company Total Assets

- debt and liquidity data:

Debt to Equity Ratio Centogene N.V.|CNTG - Long-Term Debt to Capital|Short-Term Debt to Capital centogene.com|CNTG - Company Debts|Debt to Book Value Ratio Centogene NV

Basic company analysis:CNTG - CENTOGENE N.V.

Centogene N.V. is developing a unique genetic data ecosystem, yet the restructuring of its debt profile makes the analysis of the company's balance sheet equity critically important. This indicator reflects the difference between total assets and all liabilities, allowing investors to assess the real value of net assets and the business's resilience against inflationary depreciation amid slowing operational growth.

Competitor analysis for Centogene N.V.